GNH USA

Europe — EMA

Nebivolol

GNH USA supplies Nebivolol, a beta blocker indicated for hypertension and heart failure, manufactured to EU standards. Request a quote for global supply.

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebivolol, is a beta blocker presented as an oral tablet for oral administration. It selectively blocks β1‑adrenergic receptors and also promotes nitric‑oxide mediated vasodilation, helping to lower blood pressure and improve cardiac output in patients with hypertension and chronic heart failure.

GNH USA supplies Nebivolol as a licensed, GDP‑compliant international pharmaceutical product, providing reliable sourcing to hospitals, pharmacies, and clinics across Europe, Asia, Africa and the Americas. The company adheres to stringent quality standards and offers regulatory support for global distribution.

What is Nebivolol used for?

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management.

Hypertension: lowers systolic and diastolic blood pressure, improving overall vascular control. Heart failure: enhances left ventricular ejection fraction and reduces hospitalization risk. Adjunct therapy: can be combined with other antihypertensives for resistant hypertension management.

What are the side effects of Nebivolol?

Nebivolol may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects: - Headache: mild to moderate headache. - Dizziness: especially on standing. - Fatigue: general tiredness. - Bradycardia: slower than normal heart rate.

Serious or Rare Side Effects: - Severe bradycardia: heart rate below 40 bpm. - Hypotension: marked drop in blood pressure. - Bronchospasm: difficulty breathing in susceptible individuals.

What precautions apply to Nebivolol?

When prescribing Nebivolol, clinicians should consider several safety measures. - Dose adjustment: required in renal or hepatic impairment. - Caution: use in patients with severe asthma or COPD. - Monitor: heart rate and blood pressure regularly. - Avoid abrupt discontinuation: may precipitate rebound hypertension. - Contraindicated: in patients with second‑degree AV block without pacemaker. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Nebivolol interact with?

Nebivolol can interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Combined β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of AV block. - Clonidine withdrawal: may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: risk of electrolyte imbalance and excessive blood pressure reduction. - Antidiabetic drugs: may mask hypoglycemia symptoms.

Frequently asked questions

What is Nebivolol used for?+
Nebivolol is a prescription beta‑blocker indicated for the management of hypertension and for treatment of chronic heart failure with reduced ejection fraction in adult patients. The drug may be used alone or in combination with other antihypertensive agents, and it is often selected for its additional nitric‑oxide mediated vasodilatory properties that can benefit cardiovascular health.
How does Nebivolol work?+
Nebivolol works by selectively blocking β1‑adrenergic receptors in the heart, which reduces sympathetic stimulation, slows heart rate, and decreases myocardial contractility, leading to lower blood pressure. At the same time, it activates endothelial nitric‑oxide synthase, increasing nitric‑oxide release that relaxes vascular smooth muscle and produces vasodilation. This dual action contributes to its antihypertensive and heart‑failure benefits.
What is the usual dose of Nebivolol?+
Dosage of Nebivolol is individualized by the prescribing clinician based on the patient’s blood pressure, heart‑failure status, renal and hepatic function, and concomitant medications. The prescriber determines the appropriate starting dose and any subsequent titration, following local labeling and clinical guidelines. Patients should follow the exact regimen provided on the prescription label.
Is Nebivolol safe in pregnancy or breastfeeding?+
Safety of Nebivolol during pregnancy and lactation has not been definitively established. Animal studies have shown adverse developmental effects, and human data are limited. Consequently, the drug should be prescribed during pregnancy or while breastfeeding only when the potential therapeutic benefit justifies the possible risk to the fetus or infant, and under close medical supervision.
How do I order Nebivolol from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation, including compliance with local regulations.
How does Nebivolol compare with other beta‑blockers?+
Compared with older non‑selective beta‑blockers such as propranolol, Nebivolol offers higher β1 selectivity and an additional nitric‑oxide mediated vasodilatory effect, which may result in fewer metabolic side effects and better tolerability. Relative to agents like atenolol, it often provides comparable blood‑pressure reduction with a lower incidence of fatigue and sexual dysfunction, though individual response varies.
What are the storage and handling requirements for Nebivolol?+
Nebivolol should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or near heat sources. Do not use the medication after the expiry date printed on the label.
How is Nebivolol administered?+
Nebivolol is administered orally, typically as a tablet that is swallowed whole with a glass of water. It may be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional to ensure consistent absorption. The dose is usually taken once daily, and the tablet should not be chewed or crushed.
What are the most serious risks associated with Nebivolol?+
The most serious risks of Nebivolol include severe bradycardia, marked hypotension, and bronchospasm in patients with underlying airway disease. These events can lead to syncope, cardiac arrest, or respiratory failure and require immediate medical attention. Patients should be monitored closely for any signs of these critical reactions.
Who should not use Nebivolol?+
Nebivolol is contraindicated in individuals with second‑degree or higher atrioventricular block without a functioning pacemaker, severe sinus bradycardia, cardiogenic shock, and in patients with known hypersensitivity to the drug or any of its excipients. It should also be avoided in patients with uncontrolled asthma or severe chronic obstructive pulmonary disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Crescent Pharma Limited
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA